SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare informs about reconstitution of committees of board

31 Oct 2024 Evaluate
In terms of Regulation 30 of SEBI (Listing Obligation Disclosure Requirement) Regulations, 2015 and in addition to disclosure regarding appointment of Director dated October 31st 2024, Remedium Lifecare has informed that the Board considered and approved Reconstitution of the Committees. Further to announcement dated October 31st 2024, it enclosed composition of the Committees of the Board.

The above information is a part of company’s filings submitted to BSE.

Supha Pharmachem Share Price

0.27 -0.01 (-3.57%)
15-Jun-2026 12:23 View Price Chart
Peers
Company Name CMP
Redington 243.50
Amrapali Industries 36.84
Adani Enterprises 2962.10
Rashi Peripheral 561.80
PDS 309.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: